Could a common cholesterol drug help fight a rare liver disease?
Disease control
Ongoing
This Phase 3 trial tests whether taking 40 mg of simvastatin daily for 5 years can improve outcomes for people with primary sclerosing cholangitis (PSC), a rare liver disease. About 560 patients will receive either simvastatin or a placebo. Researchers will track survival, need f…
Phase: PHASE3 • Sponsor: Annika Bergquist • Aim: Disease control
Last updated Jun 26, 2026 13:35 UTC